StockData
Innoviva, Inc. logo

Innoviva, Inc. (INVA) stock

INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.30−0.19 (-1.03%)

Close on Nov 17, 2026Market cap $1.32BP/E 9.3Yield –

Innoviva price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Innoviva's price to book ratio was 1.1× on Nov 11, 2026, against 1.6× a year earlier. Over the last 5 years it ranged from 1.1× to 7.8×, with a median of 2.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×−0.6
2025Apr 30, 20251.7×+0.3
2023Apr 28, 20231.4×−0.0
2022Dec 30, 20221.4×−1.5
2021Dec 31, 20213.0×+0.4
2020Dec 31, 20202.6×−2.8
2019Dec 31, 20195.4×−3.9
2014Jul 31, 20149.3×−2.7
2013Dec 31, 201311.9×−0.6
2012Dec 31, 201212.6×–

More Innoviva figures

See a number that looks wrong?